Assay ID | Title | Year | Journal | Article |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
AID1398108 | Inhibition of human CaV3.2 expressed in HEK293 cells assessed as suppression of T-current amplitude by measuring remaining activity at 3 uM after 10 mins by whole cell patch clamp method relative to control | 2018 | Bioorganic & medicinal chemistry, 08-15, Volume: 26, Issue:15
| Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers. |
AID1379242 | Induction of NQO1 activity in mouse Hepa1c1c7 cells after 48 hrs by MTT reduction assay | 2017 | Journal of natural products, 08-25, Volume: 80, Issue:8
| DESIGNER Extracts as Tools to Balance Estrogenic and Chemopreventive Activities of Botanicals for Women's Health. |
AID1423945 | Effect on barrier function in human Caco2 cells assessed as LY transport at 10 uM pre-treated on apical side for 1 hr and measured after 48 hrs | 2017 | Journal of natural products, 04-28, Volume: 80, Issue:4
| Effect of Hops Derived Prenylated Phenols on TNF-α Induced Barrier Dysfunction in Intestinal Epithelial Cells. |
AID1379240 | Estrogenic activity at estrogen receptor alpha in human Ishikawa cells assessed as induction of alkaline phosphatase activity using p-Nitrophenol phosphate as substrate pretreated for 96 hrs followed by substrate addition measured every 15 secs by scannin | 2017 | Journal of natural products, 08-25, Volume: 80, Issue:8
| DESIGNER Extracts as Tools to Balance Estrogenic and Chemopreventive Activities of Botanicals for Women's Health. |
AID1398110 | Antihyperalgesic activity in ddY mouse assessed as suppression of partial sciatic nerve ligation-induced mechanical allodynia at 10 mg/kg, ip administered 7 days by Von Frey test | 2018 | Bioorganic & medicinal chemistry, 08-15, Volume: 26, Issue:15
| Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers. |
AID1379241 | Cytotoxicity against human Ishikawa cells after 96 hrs by SRB assay | 2017 | Journal of natural products, 08-25, Volume: 80, Issue:8
| DESIGNER Extracts as Tools to Balance Estrogenic and Chemopreventive Activities of Botanicals for Women's Health. |
AID1398114 | Inhibition of human CaV3.1 expressed in HEK293 cells assessed as suppression of T-current after 10 mins by whole cell patch clamp method | 2018 | Bioorganic & medicinal chemistry, 08-15, Volume: 26, Issue:15
| Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers. |
AID1423947 | Inhibition of TNFalpha induced barrier dysfunctionin human Caco2 cells assessed as increase in transepithelial electrical resistance at 10 uM pre-treated on apical side for 1 hr before TNFalpha stimulation on basolateral side for 72 hrs by cellZScope moni | 2017 | Journal of natural products, 04-28, Volume: 80, Issue:4
| Effect of Hops Derived Prenylated Phenols on TNF-α Induced Barrier Dysfunction in Intestinal Epithelial Cells. |
AID1423941 | Cytotoxicity in human Caco2 cells assessed as reduction in ATP metabolism at 1 to 50 uM incubated for 24 hrs by cell-titer-Glo luminescent cell viability assay | 2017 | Journal of natural products, 04-28, Volume: 80, Issue:4
| Effect of Hops Derived Prenylated Phenols on TNF-α Induced Barrier Dysfunction in Intestinal Epithelial Cells. |
AID1379243 | Cytotoxicity against mouse Hepa1c1c7 cells after 48 hrs by crystal violet staining based assay | 2017 | Journal of natural products, 08-25, Volume: 80, Issue:8
| DESIGNER Extracts as Tools to Balance Estrogenic and Chemopreventive Activities of Botanicals for Women's Health. |
AID1423948 | Inhibition of TNFalpha induced barrier dysfunctionin human Caco2 cells assessed as increase in transepithelial electrical resistance at 10 uM treated on apical side for 1 hr post TNFalpha stimulation on basolateral side for 24 hrs and measured after 72 hr | 2017 | Journal of natural products, 04-28, Volume: 80, Issue:4
| Effect of Hops Derived Prenylated Phenols on TNF-α Induced Barrier Dysfunction in Intestinal Epithelial Cells. |
AID1423940 | Cytotoxicity in human Caco2 cells assessed as reduction in ATP metabolism at 100 uM incubated for 24 hrs by cell-titer-Glo luminescent cell viability assay | 2017 | Journal of natural products, 04-28, Volume: 80, Issue:4
| Effect of Hops Derived Prenylated Phenols on TNF-α Induced Barrier Dysfunction in Intestinal Epithelial Cells. |
AID1398109 | Inhibition of human CaV3.2 expressed in HEK293 cells assessed as suppression of T-current amplitude after 10 mins by whole cell patch clamp method | 2018 | Bioorganic & medicinal chemistry, 08-15, Volume: 26, Issue:15
| Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers. |
AID1423946 | Increase in transepithelial electrical resistance in human Caco2 cells at 10 uM pre-treated on apical side and measured after 36 to 72 hrs | 2017 | Journal of natural products, 04-28, Volume: 80, Issue:4
| Effect of Hops Derived Prenylated Phenols on TNF-α Induced Barrier Dysfunction in Intestinal Epithelial Cells. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |